These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 33023028)
1. The Oncoprotein SKI Acts as A Suppressor of NK Cell-Mediated Immunosurveillance in PDAC. Ponath V; Frech M; Bittermann M; Al Khayer R; Neubauer A; Brendel C; Pogge von Strandmann E Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33023028 [TBL] [Abstract][Full Text] [Related]
2. CBP/p300 acetyltransferases regulate the expression of NKG2D ligands on tumor cells. Sauer M; Schuldner M; Hoffmann N; Cetintas A; Reiners KS; Shatnyeva O; Hallek M; Hansen HP; Gasser S; von Strandmann EP Oncogene; 2017 Feb; 36(7):933-941. PubMed ID: 27477692 [TBL] [Abstract][Full Text] [Related]
3. Radiosensitization effect by HDAC inhibition improves NKG2D-dependent natural killer cytotoxicity in hepatocellular carcinoma. Liu YF; Chiang Y; Hsu FM; Tsai CL; Cheng JC Front Oncol; 2022; 12():1009089. PubMed ID: 36185276 [TBL] [Abstract][Full Text] [Related]
4. NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class I specificities. Diermayr S; Himmelreich H; Durovic B; Mathys-Schneeberger A; Siegler U; Langenkamp U; Hofsteenge J; Gratwohl A; Tichelli A; Paluszewska M; Wiktor-Jedrzejczak W; Kalberer CP; Wodnar-Filipowicz A Blood; 2008 Feb; 111(3):1428-36. PubMed ID: 17993609 [TBL] [Abstract][Full Text] [Related]
5. The narrow-spectrum HDAC inhibitor entinostat enhances NKG2D expression without NK cell toxicity, leading to enhanced recognition of cancer cells. Zhu S; Denman CJ; Cobanoglu ZS; Kiany S; Lau CC; Gottschalk SM; Hughes DP; Kleinerman ES; Lee DA Pharm Res; 2015 Mar; 32(3):779-92. PubMed ID: 24203492 [TBL] [Abstract][Full Text] [Related]
6. Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate. Armeanu S; Bitzer M; Lauer UM; Venturelli S; Pathil A; Krusch M; Kaiser S; Jobst J; Smirnow I; Wagner A; Steinle A; Salih HR Cancer Res; 2005 Jul; 65(14):6321-9. PubMed ID: 16024634 [TBL] [Abstract][Full Text] [Related]
7. The histone deacetylase inhibitor valproic acid inhibits NKG2D expression in natural killer cells through suppression of STAT3 and HDAC3. Ni L; Wang L; Yao C; Ni Z; Liu F; Gong C; Zhu X; Yan X; Watowich SS; Lee DA; Zhu S Sci Rep; 2017 Mar; 7():45266. PubMed ID: 28338101 [TBL] [Abstract][Full Text] [Related]
8. Influence of Histone Deacetylase Inhibitors and DNA-Methyltransferase Inhibitors on the NK Cell-Mediated Lysis of Pediatric B-Lineage Leukemia. Pfeiffer MM; Burow H; Schleicher S; Handgretinger R; Lang P Front Oncol; 2013; 3():99. PubMed ID: 23641363 [TBL] [Abstract][Full Text] [Related]
9. Valproic acid upregulates NKG2D ligand expression through an ERK-dependent mechanism and potentially enhances NK cell-mediated lysis of myeloma. Wu X; Tao Y; Hou J; Meng X; Shi J Neoplasia; 2012 Dec; 14(12):1178-89. PubMed ID: 23308050 [TBL] [Abstract][Full Text] [Related]
10. Differential Effects of Histone Deacetylases on the Expression of NKG2D Ligands and NK Cell-Mediated Anticancer Immunity in Lung Cancer Cells. Cho H; Son WC; Lee YS; Youn EJ; Kang CD; Park YS; Bae J Molecules; 2021 Jun; 26(13):. PubMed ID: 34203519 [TBL] [Abstract][Full Text] [Related]
11. Panobinostat enhances NK cell cytotoxicity in soft tissue sarcoma. Lu X; Liu M; Yang J; Que Y; Zhang X Clin Exp Immunol; 2022 Aug; 209(2):127-139. PubMed ID: 35867577 [TBL] [Abstract][Full Text] [Related]
12. Synergistic enhancement of NK cell-mediated cytotoxicity by combination of histone deacetylase inhibitor and ionizing radiation. Son CH; Keum JH; Yang K; Nam J; Kim MJ; Kim SH; Kang CD; Oh SO; Kim CD; Park YS; Bae J Radiat Oncol; 2014 Feb; 9():49. PubMed ID: 24512718 [TBL] [Abstract][Full Text] [Related]
14. Liu M; Du M; Yu J; Qian Z; Gao Y; Pan W; Zhao X; Wang M; Li H; Zheng J; Huang Q; Wang LM; Xiao H Oncoimmunology; 2022; 11(1):2016158. PubMed ID: 35003895 [TBL] [Abstract][Full Text] [Related]
15. Combinations of Histone Deacetylase Inhibitors with Distinct Latency Reversing Agents Variably Affect HIV Reactivation and Susceptibility to NK Cell-Mediated Killing of T Cells That Exit Viral Latency. Covino DA; Desimio MG; Doria M Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206330 [TBL] [Abstract][Full Text] [Related]
16. The histone deacetylase inhibitor SAHA simultaneously reactivates HIV-1 from latency and up-regulates NKG2D ligands sensitizing for natural killer cell cytotoxicity. Desimio MG; Giuliani E; Doria M Virology; 2017 Oct; 510():9-21. PubMed ID: 28689087 [TBL] [Abstract][Full Text] [Related]
17. Valproic acid upregulates NKG2D ligand expression and enhances susceptibility of human renal carcinoma cells to NK cell-mediated cytotoxicity. Yang F; Shao Y; Yang F; Liu M; Huang J; Zhu K; Guo C; Luo J; Li W; Yang B; Shi J; Zheng J Arch Med Sci; 2013 Apr; 9(2):323-31. PubMed ID: 23671445 [TBL] [Abstract][Full Text] [Related]
18. Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D. Sayitoglu EC; Georgoudaki AM; Chrobok M; Ozkazanc D; Josey BJ; Arif M; Kusser K; Hartman M; Chinn TM; Potens R; Pamukcu C; Krueger R; Zhang C; Mardinoglu A; Alici E; Temple HT; Sutlu T; Duru AD Front Immunol; 2020; 11():40. PubMed ID: 32082316 [TBL] [Abstract][Full Text] [Related]
19. Valproic acid sensitizes pancreatic cancer cells to natural killer cell-mediated lysis by upregulating MICA and MICB via the PI3K/Akt signaling pathway. Shi P; Yin T; Zhou F; Cui P; Gou S; Wang C BMC Cancer; 2014 May; 14():370. PubMed ID: 24885711 [TBL] [Abstract][Full Text] [Related]
20. Sodium butyrate upregulates expression of NKG2D ligand MICA/B in HeLa and HepG2 cell lines and increases their susceptibility to NK lysis. Zhang C; Wang Y; Zhou Z; Zhang J; Tian Z Cancer Immunol Immunother; 2009 Aug; 58(8):1275-85. PubMed ID: 19139882 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]